Ger van Jeveren
InvestorInvestor in Endeit Capital Fund III at Endeit Capital · Investor in Slingshot Ventures 3 at Slingshot Ventures · Investor at Peak
Netherlands
Writes $260K – $4.2M checks · typically $2.2M
Find your path to Ger
86 people in our graph share verified history with Ger — schools, employers, funds. One of them is your warm intro.
Stefan BaryunlockedGer: together at Peak (2019–2026)
×11Ger: together at Peak
About
Ger van Jeveren is an investor in Photon Ventures Fund 1 and holds investments in private equity and pharmaceutical companies. He previously founded and served as CEO of Fagron and Arseus, both publicly listed companies on the Amsterdam and Brussels exchanges. He holds the position of Entrepreneur in Residence at TU Delft.
Experience
- Self-employedInvestor in Photon Ventures Fund 1current2023 — present
- PeakInvestor in Peak Capital III Opportunity Fundcurrent2022 — present
- PeakInvestor in Peak Capital IVcurrent2019 — presentThe Randstad, Netherlands
- Quadrum CapitalInvestor in Quadrum Investment Fund IVcurrent2022 — present
- Quadrum CapitalInvestor in Quadrum Investment Fund IIIcurrent2020 — presentNetherlands
- Slingshot VenturesInvestor in Slingshot Ventures 3current2021 — present
- Self-employedInvestor in Dutch Star Companies Twocurrent2020 — presentNetherlands
- Endeit CapitalInvestor in Endeit Capital Fund IIIcurrent2021 — presentNetherlands
- NewPort CapitalInvestor in Newport Capital Icurrent2019 — presentAmsterdam en omgeving, Nederland
- Pharma Chemicals FranceShareholder Pharma Chemicals Francecurrent2019 — present
- Pharma ChemicalsShareholder Pharma Chemicals BVBAcurrent2018 — present
- Ace Pharmaceuticals Belgium BVShareholder Ace Pharmaceuticals Belgium BVcurrent2019 — present
- YES!DelftEntrepreneur In Residence (EIR) in medical and biotech scale upscurrent2017 — presentDelft, South Holland, Netherlands
- FagronFounder CEO Fagron1990 — 2015Rotterdam, South Holland, Netherlands
- ArseusCEO2007 — 2015Ghent Metropolitan Area
- Omega Pharma, A Perrigo CompanyMember Board Of Directors2002 — 2007Ghent Metropolitan Area
Skills & more
Entrepreneurship Development5Corporate Development5Executive Management2Venture Capital1Start-up VenturesHealthcareHigh-growthStart-upsBusinessownersscale upBoard LevelStartup Development
From Ger's professional profile.
Colleagues at Endeit Capital
Berend van Nieuwland
AI Developer at Endeit Capital
Boris Copraij
Finance Assistant at Endeit Capital
Carin Stjernefeldt
Associate at Endeit Capital
Christian Stiebner
Venture Partner at Endeit Capital
Edwin Hengstmengel
Partner at Endeit Capital
Emmelie Meurs
Associate at Endeit Capital
Fredrik Brändström
Associate at Endeit Capital
Hubert Deitmers
Managing Partner at Endeit Capital
Network1
Investors connected to Ger in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Ger van Jeveren?
- Ger van Jeveren is an investor in Photon Ventures Fund 1 and holds investments in private equity and pharmaceutical companies. He previously founded and served as CEO of Fagron and Arseus, both publicly listed companies on the Amsterdam and Brussels exchanges. He holds the position of Entrepreneur in Residence at TU Delft.
- Where does Ger van Jeveren work?
- Ger van Jeveren is Investor in Endeit Capital Fund III at Endeit Capital.
- What check size does Ger van Jeveren write?
- Ger van Jeveren typically writes checks of $260K – $4.2M.
- Where did Ger van Jeveren go to school?
- Ger van Jeveren studied at Lerarenopleiding Zuid-West Nederland, Delft (second grade Teacher, Education).
